“School of Cognitive Sciences”
Back to Papers HomeBack to Papers of School of Cognitive Sciences
| Paper IPM / Cognitive Sciences / 12826 |
|
||||||||||
| Abstract: | |||||||||||
|
Background: Several investigations have indicated that cholestasis decreases opioid receptor expression in the brain following increased opioidergic neurotransmission. The opioidergic system plays an important role in regulation of reward circuits that may be produced via dopamine-dependent mechanisms. It has been suggested that the dopaminergic system of the nucleus accumbens is necessary in conditioned place preference (CPP). The aim of this study is, therefore,
to test if cholestasis can alter the reward system and the involvement of opioidergic and dopaminergic systems in this phenomenon. Methods: We used CPP and hole-board paradigms to measure the reward effect and exploratory behaviors, respectively, in mice. Cholestasis was induced by ligation of the main bile duct, using two ligatures and transecting the duct between them (BDL mice). Results: The data showed that morphine (1 and 2 mg/kg), sulpiride (80 mg/kg) and
SKF38393 (20 mg/kg) produced CPP, while naloxone (1 mg/kg) and SCH23390 (1mg/kg) produced conditioned place aversion (CPA), whereas quinpirole had no effect in sham-operated mice. However, morphine (2 mg/kg, i.p.), sulpiride (40 mg/kg) and SKF38393 (10 mg/kg) induced CPP in BDL mice compared to sham-operated mice. Naloxone- or SCH23390-induced CPA was reduced in BDL mice compared with the respective sham-operated mice. Quinpirole tended
to induce aversion in BDL mice which was, however, not signicant. In addition, quinpirole 1 mg/kg) and SCH23390 (1 mg/kg) increased head-dip exploratory behavior, whereas naloxone (2 mg/kg) caused a decrease in head-dip exploratory behavior in sham-operated mice.
orphine (2 mg/kg), SCH23390 (1 mg/kg) and quinpirole (0.25 and 0.5 mg/kg) induced anxiogenic-like behavior in BDL mice. Conclusion: It can be concluded that cholestasis differentially alters the reward effects of opioidergic and dopaminergic agents.
Download TeX format |
|||||||||||
| back to top | |||||||||||
